Assessment and characterisation of post‐COVID‐19 manifestations
Open accessAbstract
BACKGROUND: Post-COVID-19 symptoms and diseases appeared on many survivors from COVID-19 which are similar to that of the post-severe acute respiratory syndrome (SARS) fatigue. Hence, the study aims to investigate and characterise the manifestations which appear after eradication of the coronavirus infection and its relation to disease severity. METHOD: About 287 survivors from COVID-19 were included in the study, each received a questionnaire divided into three main parts starting from subjects' demographic data, data about the COVID-19 status and other comorbidities of the subject, and finally data about post-COVID-19 manifestations. Response surface plots were produced to visualise the link between several factors. RESULTS: Only 10.8% of all subjects have no manifestation after recovery from the disease while a large percentage of subjects suffered from several symptoms and diseases. The most common symptom reported was fatigue (72.8%), more critical manifestations like stroke, renal failure, myocarditis and pulmonary fibrosis were reported by a few percent of the subjects. There was a relationship between the presence of other comorbidities and severity of the disease. Also, the severity of COVID-19 was related to the severity of post-COVID-19 manifestations. CONCLUSION: The post-COVID-19 manifestation is largely similar to the post-SARS syndrome. All subjects recovered from COVID-19 should undergo long-term monitoring for evaluation and treatment of symptoms and conditions that might be precipitated with the new coronavirus infection.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football
Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., Alosco, M. L., Solomon, T. M., Nowinski, C. J., McHale, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.8334 · Cited by 1,098 · see citing works
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chen, C., Zhang, Y., Huang, J., Yin, P., Cheng, Z., Wu, J., Chen, S., Zhang, Y., Chen, B., Lu, M., et al. (2020) · doi:10.1101/2020.03.17.20037432 · Cited by 852 · cited 1× · see citing works
“A lot of medications were included in clinical trials to act as antiviral but there are no clear results to indicate the confirmed effect for any of the investigated medications [7-9].”
BackgroundMoldofsky, H., & Patcai, J. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-37 · Cited by 604 · see citing works
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19
Fadel, R. A., Morrison, A. R., Vahia, A. T., Smith, Z., Chaudhry, Z., Bhargava, P., Miller, J. B., Kenney, R. M., Alangaden, G. J., Ramesh, M. S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa601 · Cited by 461 · see citing works
Lara, B., Carnes, A., Dakterzada, F., Benitez, I., & Piñol‐Ripoll, G. (2020) · European Journal of Neurology · doi:10.1111/ene.14339 · Cited by 197 · see citing works
Fatal pulmonary fibrosis: a post-COVID-19 autopsy case
Schwensen, H. F., Borreschmidt, L. K., Storgaard, M., et al. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206879 · Cited by 90 · see citing works
Flagged first, then by citations
Research works printed but not linked: 17
- [1]1. Wu Z, McGoogan JMJJ. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. 2020. [DOI] [PubMed]
- [2]2. COVID, C . Severe outcomes among patients with coronavirus disease 2019 (COVID‐19)—United States. February 12–March 16, 2020. [DOI] [PMC free article] [PubMed]
- [3]3. Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;23(11):1061‐1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5]5. Udugama B, Kadhiresan P, Kozlowski HN, et al. Diagnosing COVID‐19: the disease and tools for detection. ACS Nano. 2020;14(4):3822‐3835. [DOI] [PubMed] [Google Scholar]
- [6]6. Li T, Lu H, Zhang W. Clinical observation and management of COVID‐19 patients. Emerg Microbes Infect. 2020;9(1):687‐690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7]7. Gao J, Tian Z, Yang XJBT. Breakthrough Chloroquine phosphate has shown apparent efficacy in treatment of COVID‐19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72‐73. [DOI] [PubMed] [Google Scholar]
- [8]8. Elfiky AA. Anti‐HCV, nucleotide inhibitors, repurposing against COVID‐19. Life Sci. 2020;248:117477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11]11. Islam MF, Cotler J, Jason LA. Post‐viral fatigue and COVID‐19: lessons from past epidemics. Fatigue: Biomedicine, Health & Behavior. 2020:8(2):61‐69. [Google Scholar]
- [13]13. Leow MKS, Kwek DS, Ng AW, et al. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clinical Endocrinology. 63(2):197‐202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14]14. Lam MH, Wing YK, Yu MW, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long‐term follow‐up. Archives of Internal Medicine. 2009;169(22):2142‐2147. [DOI] [PubMed] [Google Scholar]
- [15]15. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID‐19) infection: a systematic review and meta‐analysis. International Journal of Infectious Diseases. 2020;94:91–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16]16. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID‐19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17]17. Tansey CM, Louie M, Loeb M, et al. One‐year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Archives of Internal Medicine. 2007;167(12):1312‐1320. [DOI] [PubMed] [Google Scholar]
- [19]19. Chakraborty A, Karmakar S Impact of COVID‐19 on obsessive compulsive disorder (OCD). Iranian Journal of Psychiatry. 2020;15(3):256‐259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21]21. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID‐19). JAMA Cardiology. 2020;5:819–821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22]22. Sarma P, Kaur H, Kumar H, et al. Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: a systematic review and meta‐analysis. Journal of Medical Virology. 2020;92:776–785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23]23. Saeed H, Abdelrahim ME, Rabea H, et al. Impact of advanced patient counseling using a training device and smartphone application on asthma control. Respiratory Care. 2020;65(3):326‐332. [DOI] [PubMed] [Google Scholar] Articles from International Journal of Clinical Practice are provided here courtesy of Wiley
Cited by
Sorted by citations
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-95565-8 · Cited by 2,757 · see citing works
Symptoms, complications and management of long COVID: a review
Aiyegbusi, O. L., Hughes, S. E., Turner, G., Rivera, S. C., McMullan, C., Chandan, J. S., Haroon, S., Price, G., Davies, E. H., Nirantharakumar, K., et al. (2021) · Journal of the Royal Society of Medicine · doi:10.1177/01410768211032850 · Cited by 969 · see citing works
Physical and mental health complications post-COVID-19: Scoping review
Shanbehzadeh, S., Tavahomi, M., Zanjari, N., Ebrahimi-Takamjani, I., & Amiri-arimi, S. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110525 · Cited by 334 · see citing works
Watanabe, A., Iwagami, M., Yasuhara, J., Takagi, H., & Kuno, T. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.008 · Cited by 304 · see citing works
Post-COVID-19 fatigue: a systematic review
Joli, J., Buck, P., Zipfel, S., & Stengel, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.947973 · Cited by 155 · see citing works
- Authors
- Kamal, M., Abo Omirah, M., Hussein, A., & Saeed, H.
- Affiliations
- Fayoum University (EG)
- Department of Neurology Faculty of Medicine Fayoum University Fayoum Egypt
- Minia University (EG)
- Beni-Suef University (EG)
- Corresponding author
- Saeed, Haitham
- Venue
- International Journal of Clinical Practice
- Publisher
- Wiley
- Published
- 2020-11-03
- Volume
- 75
- Issue
- 3
- Pages
- e13746-e13746
- ISSN
- 1368-5031 (ISSN-L)
- 1742-1241
- PMC
- PMC7536922
- OpenAlex
- W3088463325
- Cited by
- 603
- References
- 6
- Citations by year
- 2026: 16 · 2025: 34 · 2024: 90 · 2023: 162 · 2022: 180 · 2021: 117 · 2020: 4
- FWCI
- 50.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- International Journal of Clinical Practice (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- long COVID, COVID-19 survivors, fatigue, disease severity, comorbidities, stroke, renal failure, myocarditis, pulmonary fibrosis, long-term monitoring
- MeSH terms
- COVID-19, SARS-CoV-2, Fatigue, Humans, Comorbidity, Severe Acute Respiratory Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
